GENI (NYSE: GENI) insider plans Rule 144 sale of 199,719 shares

Rhea-AI Filing Summary

Nicholas Taylor filed a Rule 144 notice to sell 199,719 shares of GENI common stock. The planned sale is through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $2,084,826.70 based on the figures in the form, and the company had 214,097,454 shares outstanding. The shares being sold were acquired on 01/07/2026 through restricted stock vesting from the issuer as compensation, with payment also dated 01/07/2026.

The form also reports that during the past three months, Nicholas Taylor sold 162,737 common shares for gross proceeds of $1,763,526.91. By signing, the selling holder represents they are not aware of any material adverse, non-public information about the issuer’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	199719	2084826.70	214097454	01/08/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/07/2026	Restricted Stock Vesting	Issuer			199719	01/07/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Nicholas Taylor 27 Soho Square 1st Floor London X0 W1D 3QR	Common	12/18/2025	162737	1763526.91

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the GENI Form 144 filing by Nicholas Taylor disclose?

The filing states that Nicholas Taylor plans to sell 199,719 shares of GENI common stock under Rule 144 through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of $2,084,826.70.

How many GENI shares did Nicholas Taylor acquire before this planned Rule 144 sale?

The notice shows that 199,719 common shares were acquired on 01/07/2026 via restricted stock vesting from the issuer as compensation, matching the number of shares planned for sale.

What recent GENI share sales by Nicholas Taylor are reported in the last 3 months?

The form reports that over the past three months, Nicholas Taylor sold 162,737 GENI common shares on 12/18/2025, generating gross proceeds of $1,763,526.91.

How many GENI shares are outstanding according to this Form 144 notice?

The securities information section lists 214,097,454 GENI common shares as outstanding at the time referenced in the notice.

Which broker is handling the planned GENI share sale under Rule 144?

The planned sale of 199,719 GENI common shares is listed as being executed through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917.

What representation does the seller make about GENI’s non-public information in this Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.